The role of ADAMTS‐13 in the coagulopathy of sepsis
- 1 April 2018
- journal article
- review article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 16 (4), 646-651
- https://doi.org/10.1111/jth.13953
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Assembly and Activation of Alternative Complement Components on Endothelial Cell-Anchored Ultra-Large Von Willebrand Factor Links Complement and Hemostasis-ThrombosisPLOS ONE, 2013
- Deficiency of ADAMTS-13 in pediatric patients with severe sepsis and impact on in-hospital mortalityBMC Pediatrics, 2013
- A new mouse model mimicking thrombotic thrombocytopenic purpura: correction of symptoms by recombinant human ADAMTS13Blood, 2012
- N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and miceJCI Insight, 2011
- Extracellular histones are major mediators of death in sepsisNature Medicine, 2009
- Severe Plasmodium falciparum Malaria Is Associated with Circulating Ultra-Large von Willebrand Multimers and ADAMTS13 InhibitionPLoS Pathogens, 2009
- Association Between Thrombotic Microangiopathy and Reduced ADAMTS13 Activity in Malignant HypertensionHypertension, 2008
- The combined roles of ADAMTS13 and VWF in murine models of TTP, endotoxemia, and thrombosisBlood, 2008
- ADAMTS 13 in non-thrombotic thrombocytopaenic purpura conditionsBritish Journal of Haematology, 2008
- ADAMTS‐13, von Willebrand factor and related parameters in severe sepsis and septic shockJournal of Thrombosis and Haemostasis, 2007